To the best of our knowledge, although MRI-based machine learning approaches have been demonstrated useful in predicting biomarkers of glioma, only a few studies have evaluated the value of CNNs in biomarker prediction, especially on the mutation status of PTEN. Meanwhile, no study has evaluated the combined effects of radiomics features and CNN with a deep learning-based model. The gene discussed is PTEN; the disease is glioma.